Yaimarelis Saumell Nápoles

2PUBLICATIONS
15CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 08, 2023
Nimotuzumab Concurrent with Gemcitabine as First-Line Treatment of Locally Advanced or Metastatic Pancreatic Adenocarcinoma.

Yamirka Sánchez, Martha L Concepción, Yohan Amador

|Sep 12, 2022
Nimotuzumab in the Treatment of Inoperable Esophageal Tumors of Epithelial Origin.

Sandra González Fernández, Yohan Amador García, Lucien Gregoria Boris Porras

Pageof 1